🇺🇸 FDA
Patent

US 7157554

Glycopeptide carboxy-saccharide derivatives

granted A61KA61K38/00A61K47/40

Quick answer

US patent 7157554 (Glycopeptide carboxy-saccharide derivatives) held by Theravance, Inc. expires Mon Dec 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Jan 02 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K38/00, A61K47/40, A61K47/6951, A61K9/0014